Biotricity, Inc. (OTCMKTS:BTCY – Get Free Report)’s stock price fell 4% during trading on Monday . The company traded as low as $0.92 and last traded at $0.95. 10,404 shares were traded during trading, a decline of 73% from the average session volume of 38,058 shares. The stock had previously closed at $0.99.
Biotricity Stock Performance
The business has a fifty day simple moving average of $1.72 and a 200 day simple moving average of $2.75. The stock has a market cap of $8.14 million, a price-to-earnings ratio of -0.60 and a beta of 2.34.
Biotricity (OTCMKTS:BTCY – Get Free Report) last announced its earnings results on Tuesday, November 14th. The company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.10). The business had revenue of $2.89 million during the quarter, compared to analysts’ expectations of $3.30 million. On average, equities research analysts anticipate that Biotricity, Inc. will post -1.43 EPS for the current fiscal year.
Institutional Investors Weigh In On Biotricity
Biotricity Company Profile
Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
- Five stocks we like better than Biotricity
- Investing in the Best Airline Stocks
- The most upgraded stocks in November have two things in common
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Monday.com rocked earnings like it’s the weekend
- What Are Dividend Challengers?
- Plan to own one retailer? Make it this one
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.